Grimes & Company’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $17.2K | Hold |
|
|||||
|
2024
Q2 | $19.6K | Buy |
|
|||||
|
2024
Q1 | $29.6K | Sell |
|
|||||
|
2023
Q4 | $13.3K | Sell |
|
|||||
|
2023
Q3 | $14.4K | Buy |
|
|||||
|
2023
Q2 | $15.2K | Hold |
|
|||||
|
2023
Q1 | $8.78K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $26K | Buy |
|
|||||
|
2021
Q4 | $19K | Sell |
|
|||||
|
2021
Q3 | $49K | Buy |
|
|||||
|
2021
Q2 | $51K | Buy |
|
|||||
|
2021
Q1 | $95K | Buy |
|
|||||
|
2020
Q4 | $74K | Buy |
|
|||||
|
2020
Q3 | $12K | Buy |
|
|||||
|
2020
Q2 | $13K | Buy |
|